Marian Klinger

Prof. Marian Klinger

Department of Internal Medicine and Nephrology, Institute of Medicine, University of Opole, 45-040 Opole, Poland

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2007 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
Marian KlingerMarian Klinger
Marian Klinger
MAManual Arias
Manual Arias
VVVassilis Vargemezis
Vassilis Vargemezis
ABAnatole Besarab
Anatole Besarab
WSWladyslaw Sulowicz
Wladyslaw Sulowicz
UBUlrich Beyer
Ulrich Beyer

25 November 2016 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
APAgnieszka Perkowska-Ptasinska
Agnieszka Perkowska-Ptasinska
DDDominika Deborska-Materkowska
Dominika Deborska-Materkowska
ABArtur Bartczak
Artur Bartczak
TSTomasz Stompór
Tomasz Stompór
TLTomasz Liberek
Tomasz Liberek
MDMagdalena Durlik
Magdalena Durlik
Longer life expectancy is associated with an increasing prevalence of kidney disease. Aging itself may cause renal damage, but the spectrum of kidney disorders that affect elderly patients is diverse. Few studies, mostly form US, Asia and West Europe found differences in the prevalence of some types of kidney diseases between elderly and younger patients based on renal biopsy findings, with varied proportion between glomerulopathies and arterionephrosclerosis as a dominant injury found. Here, for the first time in Eastern Europe we analyzed native kidney biopsy findings and their relationship to clinical characteristics at the time of biopsy in elderly individuals (aged ≥65) in comparison to younger adults (aged 18–64). Biopsy and clinical data from 352 patients aged ≥65 were retrospectively identified, analyzed and compared with a control group of 2214 individuals aged 18–64. All kidney biopsies studied were examined at Medical University of Warsaw in years 2009–14. In elderly patients the leading indication for biopsy was nephrotic range proteinuria without hematuria (34.2%) and the most prevalent pathologic diagnoses were: membranous glomerulonephritis (MGN) (18.2%), focal segmental glomerulosclerosis (FSGS) (17.3%) amyloidosis (13.9%) and pauci immune glomerulonephritis (12.8%). Hypertension and age-related lesions very rarely were found an exclusive or dominant finding in a kidney biopsy (1.7%) and a cause of proteinuria (1.1%) in elderly individuals. There were 18.2% diabetics among elderly individuals, and as much as 75% of them had no morphologic signs of diabetic kidney disease in the renal biopsy. Amyloidosis, MGN, pauci immune GN, crescentic GN and light and/or heavy chain deposition disease (LCDD/HCDD) were more frequent whereas IgA nephropathy (IgAN), lupus nephritis (LN) and thin basement membrane disease (TBMD) were less common among elderly than in younger patients. Proteinuria, a dominating manifestation in elderly patients subjected to kidney biopsy was most commonly related to glomerulopathies. The relatively high prevalence of potentially curative kidney diseases in elderly individuals implicates the importance of renal biopsy in these patients.

1 July 2011
Verified
Journal Article
Closed access
EWEwa Watorek
Ewa Watorek
MBMaria Boratynska
Maria Boratynska
DSDanuta Smolska
Danuta Smolska
DPDariusz Patrzalek
Dariusz Patrzalek
Marian KlingerMarian Klinger
Marian Klinger

11 August 2015 in Postępy Higieny I Medycyny Doświadczalnej
Verified
Journal Article
Open access
TGTomasz Gołębiowski
Tomasz Gołębiowski
WWWacław Weyde
Wacław Weyde
MKMariusz Kusztal
Mariusz Kusztal
TPTomasz Porazko
Tomasz Porazko
HAHanna Augustyniak-Bartosik
Hanna Augustyniak-Bartosik
Marian KlingerMarian Klinger
Marian Klinger
Diabetics with stage V chronic kidney disease (CKD) on hemodialysis (HD) are considered as "difficult patients", because of problems with creation of the vascular access. There is controversy regarding the results and recommendations for preparation of the vascular access in these patients. The aim of this retrospective study was to evaluate the results of creating different types of arteriovenous fistula (AVFs) in consecutive series of patients starting dialysis treatment. The analysis was performed in 741 patients (385 females and 356 males), average age 61.4±7 years, who started dialysis treatment in our department between January 2005 and December 2012. Native AVFs were created in all patients. No patients received an AVF requiring synthetic graft material. The number of patients with diabetic nephropathy was 166 (22.4%). Among them, 30 (18%) had type 1 diabetes and 136 (82%) type 2. In this group the occurrence of calcification in the forearm artery was estimated on the basis of physical examination, Allan's test, Doppler ultrasound and forearm X-ray. In a subgroup of patients with atherosclerotic changes in the arterial system the frequency of failed AVFs was analyzed. These results were compared with the group without diabetes. The number of procedures necessary for successfu AVF creation and type of access was counted in both groups. The assessment of the procedure frequency and AVF location in diabetic and in non-diabetic patients was made by χ² test with Yates correction. In the group of 166 patients with diabetes, in 100 cases (60%) atherosclerotic changes in forearm arteries were observed. In a subgroup of 30 patients with type 1 diabetes atherosclerosis was observed in 17 adults (57%). In this subgroup creation of a suitable forearm AVF in the first procedure in 9 patients was possible and in the other 8 cases the atherosclerotic changes necessitated repeated procedures and were an important obstacle to create the AVF. In the subgroup of 136 patients with type 2 diabetes, atherosclerosis in the forearm artery was observed in 83 cases (61%). In this subgroup the creation of a native AVF was possible in 40 patients during the first procedure and in 43 cases additional intervention was needed, but only in 8 cases was atherosclerosis the cause of fistula failure. Generally, among 166 patients only in 16 cases (10%) did atherosclerosis present an important obstacle for AVF creation, but the number of necessary procedures to create one functioning AVF was significantly greater in this population (2 v 2.7, p=0.0001). A functioning AVF in patients with diabetes was found significantly frequently in the arm localization in comparison to non-diabetic patients (4.3 v 2%, p=0.0478). Atherosclerotic changes in forearm arteries in diabetic patients appear in 60% of hemodialysis patients and make it difficult to create an AVF only in 10% of diabetic patients, but it is possible to create a native AVF in 90% of diabetic patients, although this requires more procedures. In patients with diabetes, AVF in the wrist region should be preferred.

1 September 2017 in Clinical Biochemistry
Verified
Journal Article
Closed access
KJKatarzyna Jakuszko
Katarzyna Jakuszko
MKMagdalena Krajewska
Magdalena Krajewska
KKKatarzyna Kościelska-Kasprzak
Katarzyna Kościelska-Kasprzak
MMMarta Myszka
Marta Myszka
ASAgata Sebastian
Agata Sebastian
Marian KlingerMarian Klinger
Marian Klinger

TGTomasz Gołębiowski
Tomasz Gołębiowski
JKJakub Kuźniar
Jakub Kuźniar
TPTomasz Porazko
Tomasz Porazko
RWRenata Wojtala
Renata Wojtala
AKAndrzej Konieczny
Andrzej Konieczny
Marian KlingerMarian Klinger
Marian Klinger
The over-secretion of monoclonal immunoglobulin light chains by clonal B cells followed by the aggregation and extracellular deposition of fibrillar deposits are responsible forthe clinical course AL amyloidosis. It is well documented that silica significantly increases the number of immunoglobulin-secreting cells. In the present paper, we report on a coal miner with silicosis and fast progressing primary amyloidosis with predominantly heart, kidney, and lung manifestations. Severeheart failure due to myocardial hypertrophy resulted in the patient’s death. We conclude that long-term environmental silica exposure and silica deposition may contribute to the development of monoclonal gammopathy and amyloidosis due to chronic stimulus and the dysregulation of the immune system.